Bayer | BAYN - Market Capitalization


Bayer reported EUR36.85B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Air Liquide EUR 92.72B 8.6B Dec/2025
Akzo Nobel EUR 8.42B 1.71B Mar/2026
Alcon AG USD 37.06B 5.98B Mar/2026
Amarin USD 290M 51M Dec/2025
Arkema EUR 4.43B 467.77M Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
BASF EUR 46.77B 7.11B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
Beiersdorf EUR 22.73B 3.43B Dec/2025
Corteva USD 56.2B 10.91B Mar/2026
Covestro EUR 12.54B 1.53B Dec/2025
Essilor EUR 125.04B 18.49B Dec/2025
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Henkel EUR 29.28B 1.43B Dec/2025
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Linde USD 199.1B 22.7B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Nutrien USD 36.31B 6.48B Mar/2026
Philips EUR 22.47B 96.29M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
SAP EUR 180.47B 75.49B Mar/2026
Solvay EUR 2.8B 74.11M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025
Umicore EUR 4.41B 1.34B Dec/2025
Vinci EUR 69.85B 2.94B Dec/2025